Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether NXL104 plus ceftazidime is effective in the treatment of complicated intra-abdominal infections as compared to a comparator group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00752219
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 2
Start date March 31, 2009
Completion date December 31, 2009

See also
  Status Clinical Trial Phase
Completed NCT00389987 - Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037) Phase 3
Completed NCT02784704 - Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections Phase 3
Completed NCT01072539 - Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Completed NCT03830333 - Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015) Phase 3
Not yet recruiting NCT03678298 - Italian Register for the Study of Complicated Intra-Abdominal Infections
Active, not recruiting NCT00860587 - Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections N/A
Completed NCT01844856 - Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections Phase 3
Completed NCT02475733 - Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs). Phase 2
Completed NCT00683332 - Post-Marketing Study Of The Safety Of Tygacil (Tigecycline) N/A